Antinociceptive effects of intracerebroventricularly administered P2 purinoceptor agonists in the rat

European Journal of Pharmacology

Volumn 419, Issue 1, 2001, Pages 25-31

  Fukui, Masato ^a   Nakagawa, Takayuki ^a   Minami, Masabumi ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

, Methylene ATP; Antinociception; ATP; Purinoceptor

Indexed keywords

2',3' O (4 BENZOLYBENZOYL)ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA BETA METHYLENE ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; HOT PLATE TEST; MALE; MECHANICAL STIMULATION; MOTOR PERFORMANCE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; THERMAL STIMULATION;

ADENOSINE TRIPHOSPHATE; ANALGESICS; ANIMALS; BACLOFEN; GABA AGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2;

EID: 0035805382     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00947-5     Document Type: Article

References (53)

1. Bardoni R., Goldstein P., Justin L., Gu J., Macdermott A. ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J. Neurosci. 17:1997;5297-5304.
2. Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C., Alexander K.M., Park H.S., Yu H., Metzger R., Kowaluk E., Jarvis M.F., van Biesen T. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol. 376:1999;127-138.
3. Bland-Ward P.A., Humphrey P.P.A. Acute nociception mediated by hindpaw P2X receptor activation in the rat. Br. J. Pharmacol. 122:1997;365-371.
4. 3H] α,β-methylene-ATP binding sites in rat brain and spinal cord. NeuroReport. 5:1994;1601-1604.
5. Bo X., Schoepfer R., Burnstock G. Molecular cloning and characterization of a novel ATP P2X receptor subtype from embryonic chick skeletal muscle. J. Biol. Chem. 275:2000;14401-14407.
6. Burnstock G. Purinergic mechanisms. Ann. N. Y. Acad. Sci. 603:1990;1-18.
7. Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet. 347:1996;1604-1605.
8. Burnstock G. The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology. 36:1997;1127-1139.
9. Chen C.C., Akopian A.N., Sivilotti L., Colquuhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
10. Collo G., North R.A., Kawashima E., Merlo-Pich E., Neidhart S., Surprenant A., Buell G. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16:1996;2495-2507.
11. Cook S.P., Vulchanova L., Hargreaves K.M., Elde R., Mccleskey E.W. Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature. 387:1997;505-508.
12. Dowd E., Mcqueen D.S., Chessell I.P., Humphrey P.P.A. P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br. J. Pharmacol. 125:1998;341-346.
13. Driessen B., Reimann W., Selve N., Friderichs E., Bültmann R. Antinociceptive effect of intrathecally administered P2-purinoceptor antagonists in rats. Brain Res. 666:1994;182-188.
14. Edwards F.A., Gibb A.J., Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature. 359:1992;144-147.
15. Edwards F.A., Robertson S.J., Gibb A.J. Properties of ATP receptor-mediated synaptic transmission in the rat medial habenula. Neuropharmacology. 36:1997;1253-1268.
16. 2 purinoceptor types in rat locus coeruleus neurons. Eur. J. Pharmacol. 315:1996;255-261.
17. 3 purinoceptor. Mol. Brain Res. 47:1997;59-66.
18. Gu J.G., MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature. 389:1997;749-753.
19. Hamilton S., Wade A., McMahon S. The effects of inflammation and inflammatory mediators on nociceptive behavior induced by ATP analogues in the rat. Br. J. Pharmacol. 126:1999;326-332.
20. Harms L., Finta E.P., Tschöpl M., Illes P. Depolarization of rat locus coeruleus neurons by adenosine 5′-triphosphate. Neuroscience. 48:1992;941-952.
21. Inomata H., Ji J.J., Mimata T., Yamagata H. Concentration-related effects of extracellular application of ATP on the action potential and membrane currents of the guinea-pig vas deferens. Eur. J. Pharmacol. 202:1991;245-252.
22. Inoue K. The function of ATP receptors in the hippocampus. Pharmacol. Res. 38:1998;323-331.
23. Inoue K., Nakazawa K., Fujimori K., Watano T., Takanaka A. Extracellular adenosine 5′-triphosphate-evoked glutamate release in cultured hippocampal neurons. Neurosci. Lett. 134:1992;215-218.
24. Jo Y.H., Schlichter R. Synaptic corelease of ATP and GABA in cultured spinal neurons. Nat. Neurosci. 2:1999;241-245.
25. Kennedy C., Leff P. Painful connection for ATP. Nature. 377:1995;385-386.
26. 3 receptors in the developing rat brain. Neuroscience. 87:1998;533-539.
27. 2-purinoceptors inhibiting the release of endogenous dopamine in rat neostriatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;R33.
28. Koch H., Kügelgen I., Starke K. P2-receptor mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;707-715.
29. Koizumi S., Inoue K. Inhibition by ATP of calcium oscillations in rat cultured hippocampal neurons. Br. J. Pharmacol. 122:1997;51-58.
30. Okada M., Kawata Y., Murakami T., Wada K., Mizuno K., Kaneko S. Interaction between purinoceptor subtypes on hippocampal serotonergic transmission using in vivo microdialysis. Neuropharmacology. 38:1999;707-715.
31. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, San Diego, CA.
32. Ping L., Calejesan A.A., Zhuo M. ATP P2X receptors and sensory synaptic transmission between primary afferent fibers and spinal dorsal horn neurons in rats. J. Neurophysiol. 80:1998;3356-3360.
33. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 50:1998;413-492.
34. Sawynok J. Adenosine receptor activation and nociception. Eur. J. Pharmacol. 317:1998;1-11.
35. Sawynok J. Purines in pain management. Curr. Opin. CPNS Invest. Drugs. 1:1999;27-38.
36. Sawynok J., Reid A. Peripheral adenosine 5′-triphosphate enhances nociception in the formalin test via activation of a purinergic P2X receptor. Eur. J. Pharmacol. 330:1997;115-121.
37. Shen K.Z., North R.A. Excitation of rat locus coeruleus neurons by adenosine 5′-triphosphate: ionic mechanism and receptor characterization. J. Neurosci. 13:1993;894-899.
38. Sneddon P., Westfall D.P., Fedan J.S. Cotransmitters in the motor nerves of the guinea pig vas deferens: electrophysiological evidence. Science. 218:1982;693-695.
39. Sperlagh B., Kittel A., Lajtha A., Vizi E.S. ATP acts as fast neurotransmitter in rat habenula: neurochemical and enzymecytochemical evidence. Neuroscience. 66:1995;915-920.
40. Stone T.W. Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neuroscience. 6:1981;523-555.
41. 7). Science. 272:1996;735-738.
42. 2x purinoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;603-609.
43. Tsuda M., Ueno S., Inoue K. In vivo pathway of thermal hyperalgesia by intrathecal administration of α,β-meATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system. Br. J. Pharmacol. 127:1999;449-456.
44. Ueno S., Harata N., Inoue K., Akaike N. ATP-gated current in dissociated rat nucleus solitarii neurons. J. Neurophysiol. 68:1992;778-785.
45. Ueno S., Tsuda M., Iwanaga T., Inoue K. Cell type-specific ATP-activated responses in rat dorsal root ganglion neurons. Br. J. Pharmacol. 126:1999;429-436.
46. Von Kügelgen I., Späth L., Starke K. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br. J. Pharmacol. 113:1994;815-822.
47. Von Kügelgen I., Koch H., Starke K. P2-receptor-mediated inhibition of serotonin release in the rat brain cortex. Neuropharmacology. 36:1997;1221-1227.
48. 2X receptors) determined by immunocytochemistry. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8063-8067.
49. White T.D. Role of adenosine compounds in autonomic neurotransmission. Pharmacol. Ther. 38:1988;129-168.
50. Williams M., Jarvis M.F. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem. Pharmacol. 59:2000;1173-1185.
51. Yonemori F., Yamaguchi T., Yamada H., Tamura A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18:1998;1099-1106.
52. 2Y purinoceptors in the rat striatum. Brain Res. 691:1995;205-212.
53. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 6:1983;109-110.